TRI Stock Analysis: Thomson Reuters Common | NASDAQ
Specialty Business Services | NASDAQ, USA | Market Cap: 44.716m USD | 12M Return: -28.2% | CA8849038812 | Charts, Fundamentals & Technical Analysis
Avg Turnover: 129M
EPS Trend: 88.5%
Qual. Beats: 1
Rev. Trend: 98.5%
Qual. Beats: 2
Warnings
Tailwinds
No distinct edge detected
Seasonality 11.7 years of data
How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.
Thomson Reuters Corporation is a Canada-based content and technology company that serves customers across the Americas, Europe, the Middle East, Africa, and the Asia Pacific through five operating segments: Legal Professionals, Corporates, Tax, Audit & Accounting Professionals, Reuters News, and Global Print. Its Legal Professionals segment delivers research and integrated workflow solutions to law firms and governments, while the Corporates segment provides content-driven technologies, including generative AI-powered compliance and workflow tools, to small businesses and multinational organizations.
The Tax, Audit & Accounting Professionals segment supplies research and workflow products to accounting and tax firms, the Reuters News segment distributes business and financial news through the Reuters News Agency, Reuters.com, Reuters Events, and other channels to media organizations, professionals, and financial firms, and the Global Print segment offers legal and tax information primarily in print format. The company is listed on NASDAQ under the ticker TRI, is classified within the Industrials sector under the Research & Consulting Services sub-industry, was founded in 1799, and is headquartered in Toronto, Canada, with The Woodbridge Company Limited as its controlling shareholder.
- Reuters News AI licensing deals boost revenue outlook
- Legal Professionals segment drives recurring subscription growth
- Global Print declines but funds aggressive share buybacks
| Net Income: 1.66b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.12 > 0.02 and ΔFCF/TA 1.74 > 1.0 |
| NWC/Revenue: -27.76% < 20% (prev -8.19%; Δ -19.57% < -1%) |
| CFO/TA 0.16 > 3% & CFO 2.87b > Net Income 1.66b |
| Net Debt (2.84b) to EBITDA (3.30b): 0.86 < 3 |
| Current Ratio: 0.51 > 1.5 & < 3 |
| Outstanding Shares: last quarter (438.6m) vs 12m ago -2.79% < -2% |
| Gross Margin: 66.46% > 18% (prev 75.25%; Δ -8.79% > 0.5%) |
| Asset Turnover: 43.43% > 50% (prev 40.64%; Δ 2.79% > 0%) |
| Interest Coverage Ratio: 13.76 > 6 (EBIT TTM 2.33b / Interest Expense TTM 169.3m) |
| A: -0.12 (Total Current Assets 2.27b - Total Current Liabilities 4.44b) / Total Assets 18.1b |
| B: 0.50 (Retained Earnings 9.04b / Total Assets 18.1b) |
| C: 0.13 (EBIT TTM 2.33b / Avg Total Assets 18.0b) |
| D: 1.60 (Book Value of Equity 11.1b / Total Liabilities 6.95b) |
| Altman-Z'' = 3.39 = A |
| DSRI: 0.96 (Receivables 1.13b/1.09b, Revenue 7.83b/7.32b) |
| GMI: 1.13 (GM 75.25% / 66.46%) |
| AQI: 1.00 (AQ_t 0.86 / AQ_t-1 0.85) |
| SGI: 1.07 (Revenue 7.83b / 7.32b) |
| TATA: -0.07 (NI 1.66b - CFO 2.87b) / TA 18.1b) |
| Beneish M = -2.89 (Cap -4..+1) = A |
As of October 14, 2026, the stock is trading at USD 105.14 with a total of 729,201 shares traded. Over the past week, the price has changed by +7.19%, over one month by -0.64%, over three months by +12.24% and over the past year by -28.17%.
Current recommended Stop Loss: 98.10 (which is 6.7% or 2 ATR below the current price).
Thomson Reuters Common has received a consensus analysts rating of 4.22. Therefore, it is recommended to buy TRI.
- StrongBuy: 9
- Buy: 4
- Hold: 5
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 122.3 | 16.3% |
P/E Trailing = 27.0892
P/E Forward = 19.685
P/S = 5.7094
P/B = 3.8313
P/EG = 1.2229
Revenue TTM = 7.83b USD
EBIT TTM = 2.33b USD
EBITDA TTM = 3.30b USD
Long Term Debt = 1.32b USD (from longTermDebt, last quarter)
Short Term Debt = 1.68b USD (from shortTermDebt, last quarter)
Debt = 3.42b USD (from shortLongTermDebtTotal, last quarter) + Leases 241.0m
Net Debt = 2.84b USD (calculated: Debt 3.42b - CCE 576.3m)
Enterprise Value = 47.6b USD (44.7b + Debt 3.42b - CCE 576.3m)
Interest Coverage Ratio = 13.76 (Ebit TTM 2.33b / Interest Expense TTM 169.3m)
EV/FCF = 21.46x (Enterprise Value 47.6b / FCF TTM 2.22b)
FCF Yield = 4.66% (FCF TTM 2.22b / Enterprise Value 47.6b)
FCF Margin = 28.29% (FCF TTM 2.22b / Revenue TTM 7.83b)
Net Margin = 21.22% (Net Income TTM 1.66b / Revenue TTM 7.83b)
Gross Margin = 66.46% ((Revenue TTM 7.83b - Cost of Revenue TTM 2.63b) / Revenue TTM)
Gross Margin QoQ = 38.02% (prev 76.38%)
Tobins Q-Ratio = 2.63 (Enterprise Value 47.6b / Total Assets 18.1b)
Interest Expense / Debt = 4.95% (Interest Expense 169.3m / Debt 3.42b)
Taxrate = 22.02% (475.0m / 2.16b)
NOPAT = 1.82b (EBIT 2.33b * (1 - 22.02%))
Current Ratio = 0.51 (Total Current Assets 2.27b / Total Current Liabilities 4.44b)
Debt / Equity = 0.31 (Debt 3.42b / totalStockholderEquity, last quarter 11.1b)
Debt / EBITDA = 0.86 (Net Debt 2.84b / EBITDA 3.30b)
Debt / FCF = 1.28 (Net Debt 2.84b / FCF TTM 2.22b)
Total Stockholder Equity = 11.7b (last 4 quarters mean from totalStockholderEquity)
RoA = 9.22% (Net Income 1.66b / Total Assets 18.1b)
RoE = 14.26% (Net Income TTM 1.66b / Total Stockholder Equity 11.7b)
RoCE = 17.95% (EBIT 2.33b / Capital Employed (Equity 11.7b + L.T.Debt 1.32b))
RoIC = 12.19% (NOPAT 1.82b / Invested Capital 14.9b)
WACC = 5.50% (E(44.7b)/V(48.1b) * Re(5.62%) + D(3.42b)/V(48.1b) * Rd(4.95%) * (1-Tc(0.22)))
Discount Rate = 5.62% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -82.56 | Cagr: -1.41%
[DCF] Terminal Value 77.97% ; FCFF base≈2.09b ; Y1≈2.39b ; Y5≈3.52b
[DCF] Fair Price = 115.8 (EV 53.0b - Net Debt 2.84b = Equity 50.2b / Shares 433.3m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 88.47 | EPS CAGR: 6.09% | SUE: 1.33 | # QB: 1
Revenue Correlation: 98.54 | Revenue CAGR: 5.09% | SUE: 1.55 | # QB: 2
EPS current Quarter (2026-09-30): EPS=0.91 | Chg30d=+0.07% | Revisions=+0% | Analysts=14
EPS current Year (2026-12-31): EPS=4.44 | Chg30d=+0.10% | Revisions=+50% | GrowthEPS=+11.5% | GrowthRev=+8.6%
EPS next Year (2027-12-31): EPS=5.08 | Chg30d=+0.00% | Revisions=+29% | GrowthEPS=+14.5% | GrowthRev=+7.7%
[Analyst] Revisions Ratio: +42% (up=7, down=2)